Department of Psychiatry and Legal Medicine

Keyphrases

1. Attention Deficit Hyperactivity Disorder 100%
2. Spain 59%
3. Borderline Personality Disorder 57%
4. Major Depressive Disorder 51%
5. Alzheimer's Disease 47%
6. Schizophrenia 45%
7. Roman 40%
8. Substance Use Disorder 36%
9. Alzheimer's Disease Model 34%
10. Healthy Controls 30%
11. Cocaine 30%
12. 3xTg-AD 30%
13. First-episode Psychosis 29%
14. Spanish Version 27%
15. Meta-analysis 27%
16. Obsessive-compulsive Disorder 27%
17. Psychiatric Disorders 25%
18. Depressive Symptoms 24%
19. Psychometric Properties 24%
20. Comorbidity 23%
21. Bipolar Disorder 23%
22. Barcelona 23%
23. Impulsivity 21%
24. Risk Factors 21%
25. Quality of Life 21%
26. Psychiatric Comorbidity 21%
27. Mental Disorders 20%
28. 3,4-methylenedioxymethamphetamine 20%
29. Personality Disorders 20%
30. Hippocampus 20%
31. Cognitive Impairment 20%
32. Dependent Patients 19%
33. Anxiety Disorders 19%
34. Adult Attention Deficit Hyperactivity Disorder 18%
35. Placebo 18%
36. Antidepressants 18%
37. Randomized Controlled Trial 18%
38. Cocaine Dependence 17%
39. Primary Care 17%
40. Alcohol 17%
41. Dual Diagnosis 17%
42. Functional Magnetic Resonance Imaging 17%
43. Obesity 17%
44. Adrenoceptors 17%
45. Catalonia 16%
46. Ecstasy 16%
47. Cannabis 16%
48. Cannabis Use 16%
49. Functional Connectivity 15%
50. Adulthood 15%
51. Systematic Meta-analysis 15%
52. Addiction 15%
53. Psychosis 15%
54. 3xTg-AD Mice 15%
55. Executive Function 15%
56. DSM-IV 14%
57. Pharmacokinetics 14%
58. Antipsychotics 14%
59. Psychotic Symptoms 14%
60. Psychopathology 14%
61. Gray Matter Volume 14%
62. Confidence Interval 13%
63. Genotype 13%
64. Copyright 13%
65. Odds Ratio 13%
66. Older Adults 13%
67. Brain Regions 13%
68. Brain-derived Neurotrophic Factor 12%
69. Mental Health 12%
70. Methadone 12%
71. Schizophrenic Patients 12%
72. COVID-19 Pandemic 12%
73. Comorbid 12%
74. HPA Axis 11%
75. Aging 11%
76. Methylphenidate 11%
77. Methadone Maintenance Treatment 11%
78. Normal Aging 11%
79. Medial Prefrontal Cortex (mPFC) 11%
80. Amygdala 11%
81. Electroconvulsive Therapy 11%
82. Clinical Characteristics 11%
83. Plasma Concentration 10%
84. Health-related Quality of Life 10%
85. Remission 10%
86. Catalan 10%
87. Clinical Trials 10%
88. Benzodiazepines 10%
89. Mindfulness 10%
90. Treatment-resistant Depression 10%
91. Cognitive Performance 10%
92. Vulnerability 10%
93. Prepulse Inhibition 10%
94. Amphetamine 10%
95. Sex Differences 10%
96. Suicide 10%
97. Panic Disorder 10%
98. Psychosocial Functioning 10%
99. Personality Traits 10%
100. Suicidal Behavior 9%